These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
394 related articles for article (PubMed ID: 17188131)
1. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m sestamibi modality? Sharma J; Mazzaglia P; Milas M; Berber E; Schuster DM; Halkar R; Siperstein A; Weber CJ Surgery; 2006 Dec; 140(6):856-63; discussion 863-5. PubMed ID: 17188131 [TBL] [Abstract][Full Text] [Related]
2. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy. Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983 [TBL] [Abstract][Full Text] [Related]
3. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging. Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041 [TBL] [Abstract][Full Text] [Related]
4. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism. Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734 [TBL] [Abstract][Full Text] [Related]
5. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783 [TBL] [Abstract][Full Text] [Related]
6. Dual-isotope 99mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan. Hassler S; Ben-Sellem D; Hubele F; Constantinesco A; Goetz C Clin Nucl Med; 2014 Jan; 39(1):32-6. PubMed ID: 24152647 [TBL] [Abstract][Full Text] [Related]
7. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460 [TBL] [Abstract][Full Text] [Related]
8. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings. Nichols KJ; Tomas MB; Tronco GG; Rini JN; Kunjummen BD; Heller KS; Sznyter LA; Palestro CJ Radiology; 2008 Jul; 248(1):221-32. PubMed ID: 18483228 [TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Tc99m-MIBI SPECT/CT Versus 4D-CT or US in Management of Patients With Hyperparathyroidism. Kedarisetty S; Fundakowski C; Ramakrishnan K; Dadparvar S Ear Nose Throat J; 2019 Mar; 98(3):149-157. PubMed ID: 30938239 [TBL] [Abstract][Full Text] [Related]
10. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188 [TBL] [Abstract][Full Text] [Related]
11. Dual-phase 99mTc sestamibi scintigraphy with neck and thorax SPECT/CT in primary hyperparathyroidism: a single-institution experience. Ciappuccini R; Morera J; Pascal P; Rame JP; Heutte N; Aide N; Babin E; Reznik Y; Bardet S Clin Nucl Med; 2012 Mar; 37(3):223-8. PubMed ID: 22310246 [TBL] [Abstract][Full Text] [Related]
12. Parathyroid scintigraphy in patients with primary hyperparathyroidism: 99mTc sestamibi SPECT and SPECT/CT. Eslamy HK; Ziessman HA Radiographics; 2008; 28(5):1461-76. PubMed ID: 18794320 [TBL] [Abstract][Full Text] [Related]
14. Huang Z; Lou C J Int Med Res; 2019 Feb; 47(2):836-845. PubMed ID: 30556441 [TBL] [Abstract][Full Text] [Related]
15. 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery. Traub-Weidinger T; Mayerhoefer ME; Koperek O; Mitterhauser M; Duan H; Karanikas G; Niederle B; Hoffmann M J Clin Endocrinol Metab; 2014 Nov; 99(11):4199-205. PubMed ID: 25029418 [TBL] [Abstract][Full Text] [Related]
16. Is dual-phase SPECT/CT with 99mTc-sestamibi better than single-phase SPECT/CT for lesion localization in patients with hyperparathyroidism? Lee SH; Shin E; Ha S; Oh JS; Song DE; Ryu JS Medicine (Baltimore); 2020 May; 99(19):e19989. PubMed ID: 32384452 [TBL] [Abstract][Full Text] [Related]
17. [False negative spect parathyroid scintigraphy with sestamibi in patients with primary hyperparathyroidism]. Paillahueque G; Massardo T; Barberán M; Ocares G; Gallegos I; Toro L; Araya AV Rev Med Chil; 2017 Aug; 145(8):1021-1027. PubMed ID: 29189860 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism. Yeh R; Tay YD; Tabacco G; Dercle L; Kuo JH; Bandeira L; McManus C; Leung DK; Lee JA; Bilezikian JP Radiology; 2019 May; 291(2):469-476. PubMed ID: 30835187 [TBL] [Abstract][Full Text] [Related]